DTwP-HBV-HIB vaccine - Biological E Ltd
Alternative Names: ComBe Five; DTwP-rHepB-HIB; DTwP-rHepB-HIB - Biological E; Hib-DTP-hepatitis-B-vaccine-Biological-E-LimitedLatest Information Update: 24 Oct 2021
At a glance
- Originator Biological E Limited
- Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 24 Jun 2017 Biological E Limited completes the phase II trial in Diphtheria, Hepatitis B, Pertussis, Tetanus and Haemophilus infections (Prevention, In infants) in Vietnam (Parenteral) (NCT02904213)
- 01 Jan 2014 Launched for Hepatitis B in India (Parenteral)
- 01 Jan 2011 Launched for Haemophilus infections in India (Parenteral)